Skip to main content
. 2017 Jun 29;8(43):74178–74187. doi: 10.18632/oncotarget.18830

Table 1. Association between CHD1L expression and various clinicopathological variables of patients with EC (Chi-square test).

Variable All cases (n=191) CHD1L protein expression P value
Low expression (n=105) High expression (n=86)
Gender 0.068
 Female 50 33 17
 Male 141 72 69
Age at surgery 0.695
 <60 125 70 55
 ≥60 66 35 31
Histology type 0.428
 Ulcerating-type 68 33 35
 Medullary-type 74 46 28
 Fungating-type 38 20 18
 Stricture-type 11 6 5
Clinical stages 0.003*
 I 19 15 4
 II 75 47 28
 III 42 23 19
 IV 55 20 35
Differentiation 0.590
 Poor 36 18 18
 Mediate 127 70 57
 Well 27 17 10
Tumor location 0.656
 Upper 27 14 13
 Middle 140 80 60
 Lower 23 11 12
Tumor size(cm) 0.612
 <4 39 25 14
 ≥4 152 80 72
Lymph node metastasis 0.000*
None 90 27 63
 <4 35 23 12
 ≥4 66 55 11

* P < 0.05 was considered significant.